Anticoagulation/Thromboembolism
RSSArticles
-
What is the Utility of Implantable Loop Recorders for Evaluating Patients with Cryptogenic Stroke?
The cause of ischemic stroke remains uncertain despite a complete diagnostic evaluation in many cases. Detection of atrial fibrillation (AF) after cryptogenic stroke would have important therapeutic implications. -
Should Asymptomatic Patients with Severe Mitral Regurgitation be Referred for Valve Repair?
In patients with severe degenerative mitral regurgitation (MR), surgery is clearly recommended in the presence of any symptoms. -
Door-to-Balloon Time Isn’t Everything: Transradial Access in Primary PCI May be Worth the Delay
The mortality benefit to percutaneous coronary intervention (PCI) is unquestioned when it comes to ST-elevation myocardial infarction (STEMI). -
Antiplatelet Agents Plus Oral Anticoagulants in Atrial Fibrillation
In patients with stable coronary artery disease and atrial fibrillation (AF) on oral anticoagulants, adding antiplatelet agents is common and recommended in guidelines, especially during the first year after an acute coronary event or revascularization. -
Current Utility of Exercise ECG Testing
Most current guidelines recommend exercise electrocardiographic (ECG) testing for suspected coronary artery disease (CAD) in patients who can exercise and have a normal resting ECG. -
Long-Term Benefits of Cardiac Resynchronization Therapy in Patients with Left Bundle Branch Block
The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) showed that implantation of a cardiac-resynchronization therapy with a defibrillator (CRT-D) in patients with left bundle-branch block (LBBB), Class I or II congestive heart failure (CHF), and an ejection fraction < 30% was associated with a significant reduction in heart-failure events over 2.4 years.